Passie T - Search Results

1

Reviewing the Potential of Psychedelics for the Treatment of PTSD.

Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E. Krediet E, et al. Among authors: passie t. Int J Neuropsychopharmacol. 2020 Jun 24;23(6):385-400. doi: 10.1093/ijnp/pyaa018. Int J Neuropsychopharmacol. 2020. PMID: 32170326 Free PMC article. Review.

2

The pharmacology of psilocybin.

Passie T, Seifert J, Schneider U, Emrich HM. Passie T, et al. Addict Biol. 2002 Oct;7(4):357-64. doi: 10.1080/1355621021000005937. Addict Biol. 2002. PMID: 14578010 Review.

3

Genuine and drug-induced synesthesia: a comparison.

Sinke C, Halpern JH, Zedler M, Neufeld J, Emrich HM, Passie T. Sinke C, et al. Among authors: passie t. Conscious Cogn. 2012 Sep;21(3):1419-34. doi: 10.1016/j.concog.2012.03.009. Epub 2012 Apr 21. Conscious Cogn. 2012. PMID: 22521474 Review.

4

Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.

Passie T, Emrich HM, Karst M, Brandt SD, Halpern JH. Passie T, et al. Drug Test Anal. 2012 Jul-Aug;4(7-8):649-59. doi: 10.1002/dta.1377. Epub 2012 Jun 26. Drug Test Anal. 2012. PMID: 22736575 Review.

5

A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.

Halpern JH, Lerner AG, Passie T. Halpern JH, et al. Among authors: passie t. Curr Top Behav Neurosci. 2018;36:333-360. doi: 10.1007/7854_2016_457. Curr Top Behav Neurosci. 2018. PMID: 27822679 Review.

6

MDA, MDMA, and other "mescaline-like" substances in the US military's search for a truth drug (1940s to 1960s).

Passie T, Benzenhöfer U. Passie T, et al. Drug Test Anal. 2018 Jan;10(1):72-80. doi: 10.1002/dta.2292. Epub 2017 Dec 5. Drug Test Anal. 2018. PMID: 28851034 Review.

7

Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers.

Passie T, Adams HA, Logemann F, Brandt SD, Wiese B, Karst M. Passie T, et al. Eur Neuropsychopharmacol. 2021 Mar;44:92-104. doi: 10.1016/j.euroneuro.2021.01.005. Epub 2021 Jan 21. Eur Neuropsychopharmacol. 2021. PMID: 33487513 Clinical Trial.

8

The pharmacology of lysergic acid diethylamide: a review.

Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A. Passie T, et al. CNS Neurosci Ther. 2008 Winter;14(4):295-314. doi: 10.1111/j.1755-5949.2008.00059.x. CNS Neurosci Ther. 2008. PMID: 19040555 Free PMC article. Review.

9

Self-Experiments with Psychoactive Substances: A Historical Perspective.

Passie T, Brandt SD. Passie T, et al. Handb Exp Pharmacol. 2018;252:69-110. doi: 10.1007/164_2018_177. Handb Exp Pharmacol. 2018. PMID: 30478735

10

Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).

Brandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, Dowling G, Dempster NM, Wallach J, Passie T, Halberstadt AL. Brandt SD, et al. Among authors: passie t. Drug Test Anal. 2020 Jun;12(6):812-826. doi: 10.1002/dta.2789. Epub 2020 Apr 20. Drug Test Anal. 2020. PMID: 32180350 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page